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PEDF (pigment-epithelium-derived factor), a member of the serpin family of protease inhibitors, is considered to be an important regulator of human eye disease and is known to inhibit angiogenesis. Abdiu et al. are the first investigators to demonstrate that PEDF can be detected in the subretinal space of patients with retinal detachment. A clear answer about its physiological or pathophysiological role is not yet possible. Since PEDF is known to induce apoptosis of microvascular endothelial cells, the authors suggest that it may have importance to prevent neovascularization of the retina. Based on previous observations that PEDF reduces and even blocks neovascularization, PEDF was suggested as a candidate in the treatment of age-related macular degeneration. A comparison of PEDF with other angiogenic factors such as vascular endothelial growth factor is certainly of interest.
Still, the presence of PEDF in the subretinal space must be interpreted with caution, since its presence might also reflect the occurrence of physiological retinal pigment epithelium wound healing mechanisms. Therefore, this work must be continued to clarify its role.
I hope that these original articles as well as the other contributions in this issue will find the attention of all interested in ophthalmic research.
Uwe Pleyer , Editor-in-Chief
Three articles in this issue of Ophthalmic Research are devoted to the role of growth factors or cytokines in ophthalmology. Indeed, they reflect that major progress has been made in our understanding of the physiologic and pathophysiologic role of these peptides and proteins. This has already led to the development of new therapies and can be expected to be just the beginning of more to come.
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This first article is a continuation of previous studies demonstrating that nerve growth factor (NGF) is an important mediator of corneal wound healing and tissue repair. The authors prospectively investigated 2 groups of cataract patients receiving either topical NGF or hyaluronic acid for 2 weeks. They reported that 21 days after surgery, corneal thickness as measured with optical coherence tomography was significantly reduced in patients treated with NGF. This study shows that topical application of the heterologous murine NGF preparation was well tolerated and did not lead to undesired effects. Even if it is not very likely that NGF will become a standard treatment following cataract surgery, it may pave the way for other indications. Neurotrophic corneal alterations are not rare, and other surgical interventions such as Lasik or penetrating keratoplasty are even more likely to profit from such application. However, the introduction of recombinant NGF might be awaited. IL-6 and IL-8 are not only considered as proinflammatory cytokines but are also important modulators of wound healing. Fodor et al. determined the levels of IL-6 and IL-8/CXCL-8 in tears of normal individuals and patients with infectious conjunctivitis and various postsurgical conditions (keratoplasty, cataract). Interestingly IL-6 was detected even in normal tears, supporting previous findings that this cytokine is probably produced by ocular surface cells in their quiescent state. However, a significant in-
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